March 27, 2024 BIO INX and Rousselot: Collaboration in 3D Bioprinting

BIO INX, a leading material developer for 3D bioprinting, proudly announces a strategic collaboration with Rousselot.

In a significant leap forward for the field of 3D bioprinting, BIO INX, a leading material developer for 3D bioprinting, proudly announces the strategic collaboration with Rousselot, a global leader in gelatin- and collagen-based solutions This collaboration underscores BIO INX’ and Rousselot’s commitment to bring 3D bioprinting technologies closer to the clinic.

As part of this collaboration, BIO INX is set to distribute Rousselot’s research and technical grade X-Pure® gelatin biomaterials, renowned for their quality and reliability. The X-Pure gelatin range will be seamlessly integrated into BIO INX’ offerings, making these cutting- edge materials accessible to researchers and academics worldwide through the webshop of BIO INX.

The partnership extends beyond mere distribution, as BIO INX introduces an innovative product, the X-Pure version of their renowned extrusion bioink, GEL-MA INX©. This pioneering bioink, produced in collaboration with Rousselot, is the first step towards a GMP-like gelatin-based bioink which enables to print constructs in the presence of living cells in a straightforward manner. The development is in line with the mission of BIO INX® to make bioprinting turnkey. It represents a significant stride towards bringing the technology of 3D bioprinting closer to the clinic by enhancing reproducibility and standardization while adhering to the elevated quality requirements.

This collaboration builds upon a longstanding relationship between BIO INX and Rousselot. Namely, BIO INX, is a spin-off company from the Polymer Chemistry and Biomaterials Group at Ghent University, where the original Gelatin Methacryloyl (GEL-MA) was developed and patented 25 years ago using Rousselot gelatin, under the supervision of prof. Etienne Schacht. The research group is currently co-led by Professor Sandra Van Vlierberghe, one of the cofounders of BIO INX.

‘Ever since the original publication on GEL-MA in 2000, the material has grown in popularity, becoming one of the reference materials in tissue engineering and 3D bioprinting research worldwide. Now, this collaboration with Rousselot also adds reproducibility to the mix. The added standardization and quality were the missing link to bring this material from academic research to real life applications. Comments prof. Sandra Van Vlierberghe

“This collaboration represents the culmination of years of shared vision and innovation between BIO INX and Rousselot to increase standardization and quality in biomaterials for tissue engineering and 3D bioprinting. By integrating Rousselot’s X-Pure gelatin biomaterials into our portfolio and introducing a GMP-like bioink, we are not only advancing the capabilities of 3D bioprinting but also building further on our roots and the groundbreaking work of the research group at Ghent University prior to incorporation,” commented Jasper Van Hoorick, CEO of BIO INX.

Furthermore, this collaboration provides a significant boost to the Ghent region’s expertise in gelatin and gelatin-based products. The synergy of BIO INX, a leader in biomaterials for high resolution 3D bioprinting, and Rousselot, a global leader in gelatin products, proves to be greater than the sum of its parts. This partnership is poised to enhance the region’s longstanding legacy of excellence in gelatin expertise.

Tanja Vervust, Global Director of Rousselot Biomedical states:
“Collaborating with BIO INX to offer online-purchasing streamlines the ordering process and provides efficient delivery of high-quality gelatins necessary for tissue engineering and biofabrication projects,” said Tanja Vervust, Global Director, Rousselot Biomedical. ”Rousselot’s research-grade X-Pure gelatins are functionally equivalent to GMP-grade gelatins and help to reduce development variability and facilitate the transition to clinical applications.”

For further information and to explore the X-Pure gelatin materials and the GMP-like GEL- MA INX, please visit the BIO INX website: www.bioinx.com

About BIO INX:
BIO INX is a pioneering developer of materials for 3D bioprinting, committed to advancing the frontiers of healthcare through innovative solutions. As a spin-out from Ghent University and the Vrije Universiteit Brussel, BIO INX has established itself as a market leader in bio inks for high resolution bioprinting, focusing on materials for both extrusion- and light-based high-resolution printing technologies and offering a diverse portfolio of bio inks for various 3D bioprinting technologies.

Contact:

Jasper Van Hoorick,
CEO, BIO INX
E : Jasper.vanhoorick@bioinx.com
T : +32 499 16 98 94
www.bioinx.com

About Rousselot
Rousselot, the brand of Darling’s Ingredients Health, is a global leader in gelatin- and collagen-based solutions for the food, health & nutrition, biomedical and pharmaceutical industries. Working in partnership with our global customer base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers and contribute to public health. Through our state-of-the-art operations, extensive technical expertise and sustained scientific research, we help our customers achieve their goals and create world- class products.

Leveraging over 130 years of experience in pharmaceutical gelatins, Rousselot has recently expanded into a dedicated line of biomaterials for the biomedical industry. Our comprehensive portfolio includes purified, modified, and unmodified gelatins, all designed to guarantee performance, quality, and safety throughout the development process – from bench to clinic. www.rousselot.com/biomedical

Contact: Caroline Brochard-Garnier
Director Communications & PR, Rousselot
E: Caroline.brochard-garnier@rousselot.com

Subscribe to Industry Today